Sentences with phrase «for pharmaceutical compounding»

Not exact matches

Assuming that the patented compound even makes it to the market, the statement that they only have a few years of exclusivity is definitely true — the market exclusivity for pharmaceuticals is almost always less than half of the patent exclusivity.

The global market for pharmaceutical contract manufacturing, contract research and contract packaging will grow from $ 136.4 billion in 2017 to $ 197.0 billion by 2022 with a compound annual growth rate (CAGR) of 7.6 % for the period of 2017 - 2022.

A pharmaceutical hit compound, like those discovered by Vogel and her co-authors, is a compound that is a promising candidate for chemical modification so it can eventually be delivered to patients as a therapeutic drug.

At the time, however, Cronin says that critics doubted whether this approach would be useful for making more complex compounds, such as pharmaceuticals.

Instead of systematically testing the effects of known compounds — the pharmaceutical industry's basic model for more than a century — scientists can now investigate backward, combing through genomic data to find links between specific genotypes and diseases and then screening drug data to identify therapeutic candidates.

Giant pharmaceutical and smaller biotech firms are searching for epigenetic compounds to boost learning and memory.

Two years ago the pharmaceutical giant GlaxoSmithKline purchased Sirtris for $ 720 million, and by August of last year The New York Times was speculating that compounds capable of activating sirtuin genes were now the leading candidates for what the newspaper called «the ultimate free lunch... a drug that tricks the body into thinking it is on [a calorie - restricted] diet.»

The university was looking for a pharmaceutical scientist to evaluate antimalarial compounds synthesized in the lab.

AquaPharm aims to find novel medicinal compounds from a variety of marine sources and licence them to pharmaceutical companies for development.

The novel technique may be useful for making compounds important in agriculture and pharmaceuticals with less damage to the environment.

So, if you are a chemist and like simulations — why not try using your knowledge and working in a young start - up, developing tools which will be used for «intelligent» discovery of new pharmaceutical compounds?

But this also provides ample time for chlorine to interact with pharmaceuticals that may be in the water, encouraging development of new antibiotic compounds.

«This finding opens up for new possibilities to stabilise the vast number of amorphous compounds in the R&D pipe - line of big pharmaceutical companies», says Maria Strömme, Professor of Nanotechnology at Uppsala University.

«We have identified a number of pharmaceutical compounds that selectively inhibit — in different experimental models — the mitochondrial enzyme responsible for the tumour growth, thus limiting fat synthesis and without harming normal cells.»

For example, the best national pharmaceutical companies are starting to invest in the validation of plant - derived medicines in an attempt to lay claim to new medicines and compete with the conventional imported compounds, which make up over 70 % of the Brazilian market.

«We test the water for over 400 compounds — pharmaceuticals, endocrine - disruptor chemicals — and we've never had a violation,» Markus says.

Those were developed, in part, as a byproduct of previous alliances in which pharmaceutical companies payed for rights to develop would - be drugs discovered at Scripps, as well as through the more traditional approach of licensing early - stage compounds to startup companies that then raise money to develop them further.

He also plans to reach out to and collaborate with biologists and medical researchers to develop active agents for pharmaceuticals to treat cancers or inflammatory diseases from these beer - inspired compounds.

The technique could make it easier to produce custom compounds for pharmaceuticals.

It is generally thought that these compounds have reached the aquatic environment for as long as they have been commercially used, but only during the last decade or so has environmental research been widely conducted and concerns over the effects of pharmaceuticals in water bodies been raised.

Chemists at The University of Texas at Arlington have devised a safer, more environmentally friendly, less expensive and more efficient water - based system for the synthesis of organic compounds typically used in pharmaceuticals, agrochemicals, cosmetics, plastics, textiles and household chemicals.

Rather than remaining unused on the shelf of a pharmaceutical company or academic laboratory, drug compounds become available for other uses.

That's part of the reason that most drugs that work in animals don't work in people — only 11 % of oncology compounds that show promise in mice are ever approved for humans — despite billions of dollars spent by pharmaceutical and biotech companies.

PsychoGenics leverages its sophisticated Cube technology platforms and broad capabilities to partner with pharmaceutical, biotechnology and not - for - profit research entities to screen diverse compound libraries and discover valuable new therapies for the CNS market.

These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

A: At the time, ideas were beginning to form about which drug compounds to test — the first gene for ALS had been identified two years earlier — but ALS wasn't grabbing the attention of the pharmaceutical industry.

Clementia Pharmaceuticals licensed palovarotene from Roche Pharmaceuticals, which previously investigated the compound as a possible treatment for chronic pulmonary disease and evaluated its safety in more than 800 healthy volunteers and patients.

He and his team, in collaboration with pharmaceutical company AstraZeneca, are currently using the new peptides to discover Gαq - blocking compounds that might be developed into treatments for this form of cancer.

Cells have become essential in modern medicine as therapies, vehicles for producing high ‑ value therapeutics, and tools for high ‑ throughput screening of pharmaceutical compounds.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

Currently, the Herlyn Laboratory collaborates with pharmaceutical companies as well as academic chemists and structural biologists to select and further develop compounds for tumor inhibition.

However, with few exceptions, the stem cell and regenerative medicine industry has remained inadequately capitalized to carry out large - scale clinical trials independently, and major pharmaceutical firms have tended to show more interest in the use of hiPSCs as a source of large, pure populations of specific somatic cells for use in drug compound screening and toxicology tests, than they have in therapeutic uses of stem cells and their derivatives.

Because only one enantiomer of a pharmaceutical (drug) is likely to be therapeutically active, chemists have devised strategies for preparing chemical compounds of only one enantiomer.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

In ensuing experiments, Dr. Ding hopes to rely only on microRNAs and pharmaceutical compounds to convert skin cells to brain cells, which should lead to more efficient generation of cells for testing and regenerative purposes.

The non-psychoactive compound is also thought to be safe and effective for treating similar conditions in animals as an alternative to pharmaceuticals.

However, the compounding pharmacy Imprimis Pharmaceuticals said it may have a version available for individual patients in a few months.

For one thing, DCA is extremely cheap, and for another, because no pharmaceutical company in existence has a patent on the DCA compound, they can not claim it as their own and profit from For one thing, DCA is extremely cheap, and for another, because no pharmaceutical company in existence has a patent on the DCA compound, they can not claim it as their own and profit from for another, because no pharmaceutical company in existence has a patent on the DCA compound, they can not claim it as their own and profit from it.

Methods of utilizing novel natural compounds and strategically incorporating some pharmaceutical options to support critical metabolic factors for long - term weight management will be discussed.

It has also been discovered in the same research that more potent drugs, with pharmaceutical compounds not unlike resveratrol, may have the potential for preventing and treating age related diseases and illnesses.

Coal is an abundant natural resource that can be used as a source of energy, as a chemical feedstock from which numerous synthetic compounds (e.g., dyes, oils, waxes, pharmaceuticals, and pesticides) can be derived, and in the production of coke for metallurgical processes.

We note that the standard for showing utility for a compound as a pharmaceutical before the patent office is much lower than that before the FDA, and that a human clinical trial is not necessary to establish utility for an invention related to treatment of human disorders.

If a client has a novel compound that is useful as an active pharmaceutical ingredient or even as an intermediate, then we try to obtain a patent on that compound for our client.

Represented petitioners and patent owners in IPR proceedings regarding patents related to chemical compounds for pharmaceutical and industrial / commercial applications.

Description: Job SummaryResponsible for all aspects of pharmaceutical care to include safe and appropriate use, managing selected drug therapies, and the dispensing, compounding, labeling, and storage of pharmaceuticals.

Inspects all products for deterioration and proper pharmaceutical characteristics to ensure high quality products, using an extensive knowledge and experience of a large variety of compounded products.

The Pharmacy Technician - Certified, under the immediate oversight of the Pharmacist, shall support the mission of the hospital and pharmacy department and is responsible for the efficient, accurate and timely preparation, compounding, labeling, and delivering of pharmaceuticals to assure customer satisfaction.

The APhA Complete Review for the FPGEE ® provides a comprehensive review of basic pharmaceutical principles (dosage forms, math, bio-pharmaceutics, kinetics, basic and parenteral compounding, among others); the basic medical sciences (chemistry, biochemistry, physiology, anatomy, pharmacology, microbiology, and immunology); social and administrative sciences (practice management, pharmacoeconomics, biostatistics, health care systems, etc.); and the clinical sciences (basic therapeutics, communication skills, etc.).

The Pharmacy Technician Certified - Polk, under the immediate oversight of the Pharmacist, shall support the mission of the hospital and pharmacy department and is responsible for the efficient, accurate and timely preparation, compounding, labeling, and delivering of pharmaceuticals to assure customer satisfaction.